Nima Ghamsari, an officer and director of Blend Labs, Inc., filed a Form 144 notice of proposed sale with the SEC on October 26, 2026, covering 21,368 shares of Blend Labs common stock with an aggregate market value of $23,903.00.

Key Highlights

  • Proposed sale: Nima Ghamsari, officer and director, intends to sell 21,368 shares of Blend Labs common stock through Charles Schwab & Co., Inc.
  • Aggregate market value: The shares carry a stated aggregate market value of $23,903.00, according to the filing.
  • Source of shares: The securities were acquired on November 20, 2025 via a restricted stock lapse from Blend Labs, Inc., classified as equity compensation.
  • Shares outstanding: The filing reports 233,256,934 shares of common stock outstanding.
  • Trading plan: The filing indicates reliance on a Rule 10b5-1 plan adopted on June 15, 2026.
  • Prior three-month sales: Ghamsari sold a total of 138,408 shares across six transactions between September 14, 2026 and October 19, 2026, generating combined gross proceeds of $149,906.00, according to the filing.
  • Exchange: The securities are listed on NYSE (NYSE:BLND), as stated in the filing.

Ghamsari's Proposed Sale Under Rule 144 at Blend Labs

According to the Form 144 filed on October 26, 2026, Nima Ghamsari, who holds the roles of both officer and director at Blend Labs, Inc., notified the SEC of a proposed sale of 21,368 shares of the company's common stock. The shares are to be sold on the NYSE with Charles Schwab & Co., Inc. serving as broker. The filing lists an aggregate market value of $23,903.00 for the proposed transaction, with an approximate sale date of October 26, 2026.

The shares subject to the proposed sale were acquired on November 20, 2025 through a restricted stock lapse from Blend Labs, Inc., with the nature of payment described in the filing as "Equity Compensation." The filing also discloses that Ghamsari is relying on a written trading plan under Rule 10b5-1, with the date of plan adoption listed as June 15, 2026.

In the three months preceding this notice, Ghamsari reported six prior sales of Blend Labs securities: 17,731 shares on September 14, 2026 (gross proceeds $25,267.00); 21,009 shares on September 21, 2026 (gross proceeds $25,024.00); 22,523 shares on September 28, 2026 (gross proceeds $24,816.00); 24,272 shares on October 5, 2026 (gross proceeds $24,649.00); 25,098 shares on October 12, 2026 (gross proceeds $24,474.00); and 27,775 shares on October 19, 2026 (gross proceeds $25,676.00). All sales were reported by Nima Ghamsari at the issuer's address at 7250 Redwood Blvd., Suite 300, Novato, California.

What Was Disclosed

Nima Ghamsari, an officer and director of Blend Labs, Inc. (NYSE:BLND), filed a Form 144 on October 26, 2026 to notify the SEC of a proposed sale of 21,368 common shares valued at $23,903.00, acquired through a November 2025 restricted stock lapse, under a Rule 10b5-1 plan adopted June 15, 2026.